Back to Archived News
Xenonics Awarded Additional U.S. Patent For Technology Used in SuperVision Night Vision Products
Tuesday, October 05, 2010
Carlsbad, CA -- Xenonics Holdings, Inc. (OTCBB & OTCQB: XNNH) announced today that the United States Patent and Trademark Office has awarded U.S. Patent No. 7,795,574 to Xenonics. The patent, which has 22 claims, covers certain technology used in Xenonics' advanced digital low-light viewing devices, including its SuperVision line of night vision products.
"Xenonics' intellectual property portfolio now includes 14 issued patents. Technology protected by nine of these patents is used in our NightHunter high-intensity illumination devices, and technology protected by the other five is used in our SuperVision night vision systems. We are developing additional patentable technologies," said Chairman Alan Magerman.
Xenonics Holdings, Inc. develops and produces advanced, lightweight and compact ultra-high-intensity illumination and low-light vision products for military, law enforcement, public safety, and commercial and private sector applications. Xenonics' NightHunter line of illumination products is used by every branch of the U.S. Armed Forces as well as law enforcement and security agencies. Its SuperVision high-definition night vision is designed for commercial and military applications. Employing patented technologies, Xenonics provides innovative solutions for customers who must see farther so they can do their jobs better and safer. Xenonics' products represent the next generation in small, high intensity, high efficiency illumination and low-light vision systems. Visit Xenonics on the web at www.xenonics.com.
Except for the historical statements, statements in this release may constitute forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934.When used, the words "anticipates," "believes," "expects," "intends," "future," and other similar expressions identify forward-looking statements. These forward-looking statements reflect management's current views with respect to future events and financial performance and are subject to risks and uncertainties, and actual results may differ materially from the outcomes contained in any forward-looking statement. Factors that could cause these forward-looking statements to differ from actual results include delays in development, marketing or sales of new products, and other risks and uncertainties discussed in the company's periodic reports on Form 10-K and 10-Q and other filings with the Securities and Exchange Commission. Xenonics Holdings undertakes no obligation to update or revise any forward-looking statements.
Back to Archived News